Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Celularity Inc.

Celularity Inc. (GXGX) Stock Overview

Explore Celularity Inc.’s financial performance, market position, analyst ratings, and future outlook.

GXGX●NASDAQ
Financial ServicesShell Companies
$10.20
$2.18(27.18%)
U.S. Market opens in 5h 17m

Celularity Inc. (GXGX)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E Ratio-2.84
EPS (TTM)N/A
ROE4.12%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$8.85

GXGX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Celularity Inc. (NASDAQ: GXGX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Celularity Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GXGX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $8.85 for the NASDAQ listing.

Key metrics behind Celularity Inc.'s NASDAQ-traded stock include a P/E ratio of -2.84 and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GXGX on the NASDAQ.

Price Performance (NASDAQ: GXGX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
85.45%
3-Year Change
1.49%
5-Year Change
4.08%
All-Time (Max) Change
4.08%

Contact Information

http://celularity.com
12126163700
1325 Avenue of the Americas Fl 25, New York City, NY, 10019

Company Facts

IPO DateMay 21, 2019
CountryUS

Frequently Asked Questions